These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2972503)

  • 21. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
    Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
    Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
    [No Abstract]   [Full Text] [Related]  

  • 22. [Bronchodilator effect of methylxanthine derivatives (author's transl)].
    Werdermann K; Jorde W
    Dtsch Med Wochenschr; 1979 Sep; 104(37):1307-11. PubMed ID: 477550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe bronchial asthma improved on bamifylline. Case report and review.
    Bijl D; Speelberg B
    Respiration; 1994; 61(5):287-91. PubMed ID: 7800962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Broncholytic effect of Atrovent in comparison with a combination preparation in obstructive lung diseases].
    Holzhey P
    Wien Med Wochenschr; 1975 Dec; 125(49):711-6. PubMed ID: 1229127
    [No Abstract]   [Full Text] [Related]  

  • 25. [Management of patients with chronic obstructive pulmonary disease].
    Coll R; Morera J
    Rev Clin Esp; 1994 Dec; 194(12):1049-57. PubMed ID: 7863055
    [No Abstract]   [Full Text] [Related]  

  • 26. [A strategy of drug treatment of obstructive respiratory tract diseases].
    Slapke J; Adolph J
    Z Arztl Fortbild (Jena); 1989; 83(17):857-9. PubMed ID: 2686213
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical trial of ventax (long-acting theophylline) in chronic obstructive bronchitis].
    Nikitina AV; Karpukhina EP; Lapygina MV; Evstratov AI
    Klin Med (Mosk); 1997; 75(1):40-1. PubMed ID: 9082058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Is routine monitoring of theophylline blood levels really effective?].
    Atsmon J; Priel IE; Dolev E
    Harefuah; 1995 Nov; 129(9):304-8, 368. PubMed ID: 8549976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Objective assessment of a bronchodilator drug combination in asthmatic outpatients.
    Mattila MJ; Alanko K
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):273-84. PubMed ID: 4197251
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical results obtained from a new controlled release theophylline preparation.
    Nolte D
    Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of bronchodilators in the therapy of obstructive respiratory diseases].
    Fortschr Med; 1983 Mar; 101(10):435-6. PubMed ID: 6840647
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of theophylline and proxyphylline in the treatment of obstructive lung diseases in children: demands for new dosage routines].
    Holmen TL; Selvig K; Bjerve KS; Aas K; Rugstad HE
    Tidsskr Nor Laegeforen; 1980 Jan; 100(3):172-73. PubMed ID: 7385142
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutical effect of a new antidyspnoeic drug in the chronic obstructive pulmonary disease (author's transl)].
    Chillón F
    Folia Clin Int (Barc); 1973 Jun; 23(6):464-76. PubMed ID: 4805350
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bronchial dysreactive syndromes: bamifylline].
    Catena E; Marcatili S
    Arch Monaldi Mal Torace; 1989; 44(4-6):823-4. PubMed ID: 2577801
    [No Abstract]   [Full Text] [Related]  

  • 35. Theophylline-induced stuttering.
    Gérard JM; Delecluse F; Robience Y
    Mov Disord; 1998 Sep; 13(5):847-8. PubMed ID: 9756159
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical experience with bamifylline in children with asthmatic bronchitis or bronchial asthma].
    Mora P; De Giorgis A; Brienza T; Farri A
    Minerva Pediatr; 1986 Feb; 38(3-4):119-23. PubMed ID: 3702843
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacologic management of chronic obstructive pulmonary disease.
    Fairshter RD
    Compr Ther; 1984 Mar; 10(3):12-9. PubMed ID: 6713810
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of respiratory insufficiency in chronic nonspecific lung diseases].
    Kazanbiev NK
    Klin Med (Mosk); 1995; 73(4):24-7. PubMed ID: 7474811
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease].
    Harder S; Staib AH; Stauder J
    Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacologic modification of effort dyspnea in children with CARA].
    Neijens HJ; Wesselius TR; Kerrebijn KF
    Ned Tijdschr Geneeskd; 1981 Aug; 125(32):1277-81. PubMed ID: 6791036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.